Literature DB >> 26623046

Predicted extracapsular invasion of hilar lymph node metastasis by fusion positron emission tomography/computed tomography in patients with lung cancer.

Takashi Makino1, Yoshinobu Hata1, Hajime Otsuka1, Satoshi Koezuka1, Kazutoshi Isobe2, Nobumi Tochigi3, Nobuyuki Shiraga4, Kazutoshi Shibuya3, Sakae Homma2, Akira Iyoda1.   

Abstract

Intraoperative detection of hilar lymph node metastasis, particularly with extracapsular invasion, may affect the surgical procedure in patients with lung cancer, as the preoperative estimation of hilar lymph node metastasis is unsatisfactory. The aim of this study was to investigate whether fusion positron emission tomography/computed tomography (PET/CT) is able to predict extracapsular invasion of hilar lymph node metastasis. Between April, 2007 and April, 2013, 509 patients with primary lung cancer underwent surgical resection at our institution, among whom 28 patients exhibiting hilar lymph node metastasis (at stations 10 and 11) were enrolled in this study. A maximum lymph node standardized uptake value of >2.5 in PET scans was interpreted as positive. A total of 17 patients had positive preoperative PET/CT findings in their hilar lymph nodes, while the remaining 11 had negative findings. With regard to extracapsular nodal invasion, the PET/CT findings (P=0.0005) and the histological findings (squamous cell carcinoma, P=0.05) were found to be significant predictors in the univariate analysis. In the multivariate analysis, the PET/CT findings were the only independent predictor (P=0.0004). The requirement for extensive pulmonary resection (sleeve lobectomy, bilobectomy or pneumonectomy) was significantly more frequent in the patient group with positive compared with the group with negative PET/CT findings (76 vs. 9%, respectively, P=0.01). Therefore, the PET/CT findings in the hilar lymph nodes were useful for the prediction of extracapsular invasion and, consequently, for the estimation of possible extensive pulmonary resection.

Entities:  

Keywords:  2-deoxy-2-(18F)fluoro-D-glucose-positron emission tomography; extracapsular invasion; hilar lymph node; lung cancer; surgery

Year:  2015        PMID: 26623046      PMCID: PMC4534879          DOI: 10.3892/mco.2015.596

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  19 in total

1.  Fusion positron emission/computed tomography underestimates the presence of hilar nodal metastases in patients with resected non-small cell lung cancer.

Authors:  Sergio A Carrillo; Vincent C Daniel; Nathan Hall; Charles L Hitchcock; Patrick Ross; Edmund S Kassis
Journal:  Ann Thorac Surg       Date:  2012-03-17       Impact factor: 4.330

2.  Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.

Authors:  H C Steinert; M Hauser; F Allemann; H Engel; T Berthold; G K von Schulthess; W Weder
Journal:  Radiology       Date:  1997-02       Impact factor: 11.105

3.  Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.

Authors:  J F Vansteenkiste; S G Stroobants; P R De Leyn; P J Dupont; J A Verschakelen; K L Nackaerts; L A Mortelmans
Journal:  Chest       Date:  1997-12       Impact factor: 9.410

4.  Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.

Authors:  Shun-ichi Watanabe; Hisao Asamura; Kenji Suzuki; Ryosuke Tsuchiya
Journal:  Ann Thorac Surg       Date:  2005-05       Impact factor: 4.330

5.  Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).

Authors:  Gerard A Silvestri; Michael K Gould; Mitchell L Margolis; Lynn T Tanoue; Douglas McCrory; Eric Toloza; Frank Detterbeck
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

6.  FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group.

Authors:  J F Vansteenkiste; S G Stroobants; P J Dupont; P R De Leyn; W F De Wever; E K Verbeken; J L Nuyts; F P Maes; J G Bogaert
Journal:  Eur J Nucl Med       Date:  1998-11

7.  The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer.

Authors:  Valerie W Rusch; Hisao Asamura; Hirokazu Watanabe; Dorothy J Giroux; Ramon Rami-Porta; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2009-05       Impact factor: 15.609

8.  Preoperative staging of lung cancer with combined PET-CT.

Authors:  Barbara Fischer; Ulrik Lassen; Jann Mortensen; Søren Larsen; Annika Loft; Anne Bertelsen; Jesper Ravn; Paul Clementsen; Asbjørn Høgholm; Klaus Larsen; Torben Rasmussen; Susanne Keiding; Asger Dirksen; Oke Gerke; Birgit Skov; Ida Steffensen; Hanne Hansen; Peter Vilmann; Grete Jacobsen; Vibeke Backer; Niels Maltbaek; Jesper Pedersen; Henrik Madsen; Henrik Nielsen; Liselotte Højgaard
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

9.  Problems in the current diagnostic standards of clinical N1 non-small cell lung cancer.

Authors:  T Hishida; J Yoshida; M Nishimura; Y Nishiwaki; K Nagai
Journal:  Thorax       Date:  2007-11-16       Impact factor: 9.139

10.  Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer.

Authors:  Sumin Shin; Hong Kwan Kim; Yong Soo Choi; Kwhanmien Kim; Jhingook Kim; Young Mog Shim
Journal:  Ann Thorac Surg       Date:  2013-08-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.